Evidence map›Paper›PMID 26941243›Full record

ReviewWorld journal of microbiology & biotechnology2016

Bacteriophage biocontrol in wastewater treatment.

Sabah A A Jassim, Richard G Limoges, Hassan El-Cheikh

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Tools and methodology toFrontiers in microbiology · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Daily Reports on Phage-Host Interactions.Frontiers in microbiology · 2022
    Article
  14. Treating bacterial infections with bacteriophages in the 21st century.Southern African journal of infectious diseases · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Bacteriophages in water pollution control: Advantages and limitations.Frontiers of environmental science & engineering · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sabah A A JassimApplied Bio Research Inc., 455 Pelissier St., Windsor, ON, N9A 6Z9, Canada. prof.jassim@yahoo.co.uk.
Richard G LimogesApplied Bio Research Inc., 455 Pelissier St., Windsor, ON, N9A 6Z9, Canada. ricklimoges@hotmail.com.
Hassan El-CheikhApplied Bio Research Inc., 455 Pelissier St., Windsor, ON, N9A 6Z9, Canada. hassan.elcheikh.md@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Waterborne bacterial pathogens in wastewater remains an important public health concern, not only because of the environmental damage, morbidity and mortality that they cause, but also due to the high cost of disinfecting wastewater by using physical and chemical methods in treatment plants. Bacteriophages are proposed as bacterial pathogen indicators and as an alternative biological method for wastewater treatment. Phage biocontrol in large scale treatment requires adaptive and aggressive phages that are able to overcome the environmental forces that interfere with phage-host interactions while targeting unwanted bacterial pathogens and preventing biofilms and foaming. This review will shed light on aspects of using bacteriophage programming technology in wastewater plants to rapidly target and reduce undesirable bacteria without harming the useful bacteria needed for biodegradation.

Indexed as

BacteriophagesBiodegradation, EnvironmentalBiofilmsHumansLysogenyWastewaterWaterborne DiseasesWater PurificationWastewaterActivated sludge processBacteriophageBiocontrolPhage reprogramming technologySewageWastewater treatmentWater

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.